Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy

E-ISSN： 1447-0756|41|10|1630-1637

ISSN： 1341-8076

Source： JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol.41, Iss.10, 2015-10, pp. : 1630-1637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1630-1637

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiation Therapy for Chemotherapy-Resistant Recurrent Epithelial Ovarian Cancer

Oncology, Vol. 86, Iss. 4, 2014-05 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Differential cellular responses induced by dorsomorphin and LDN‐193189 in chemotherapy‐sensitive and chemotherapy‐resistant human epithelial ovarian cancer cells

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 5, 2015-03 ,pp. : E455-E469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intraperitoneal chemotherapy of ovarian cancer

By Lowe Thomas Morgan Robert J

Women's Health, Vol. 3, Iss. 4, 2007-07 ,pp. : 433-440

Future Medicine

Access to resources Recommend Favorite

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 376-381

Karger

Access to resources Recommend Favorite